Loading...
Gene And Immunotherapy Expansion Will Drive Durable Long Term Opportunity
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
1Y
448.4%7D
9.9%1Y
448.4%7D
9.9%You can edit this narrative until Dec 8 6:05 AM. Then, changes will post as Updates.